Women with Stage III
ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Med
cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology
Group (GOG), a National
Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Med
Cancer Institute - supported
research network, in the January 5, 2006 issue of the New England Journal of Medicine.